Calcimedica Inc (CALC) Stock Price, Quote & News

Company Profile

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also d...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 952 5500

Website: calcimedica.com

Address:

505 Coast Boulevard South, Suite 307, La Jolla, United States

MrAlientrader Sep. 12 at 6:16 PM

$CALC haven’t seen a stock has insiders buy so often

0 · Reply

MrAlientrader Sep. 11 at 8:21 PM

$CALC i was waiting for the drop but my order at $3.25 placed yesterday did not get filled even the price shows today’s low at $3.15

0 · Reply

pablo4 Sep. 11 at 4:12 PM

$CALC https://www.sec.gov/Archives/edgar/data/1534133/000141588925024256/xslF345X05/form4-09112025_120901.xml CBO stepping up and adding again. I've never seen insider buying this regular.

1 · Reply

InfinityVenom Sep. 10 at 5:59 PM

$CALC Im in here.

0 · Reply

MrAlientrader Sep. 10 at 2:15 PM

$CALC i almost accumulated every major dip

0 · Reply

sh64 Sep. 9 at 5:09 PM

$CALC nice

0 · Reply

OffComesTheShirt Sep. 9 at 5:09 PM

$CALC 15% Off Comes The Pants

0 · Reply

OffComesTheShirt Sep. 9 at 4:52 PM

$CALC 14% Off Comes The Shirt

0 · Reply

kshonstocks Sep. 9 at 4:27 PM

$CALC hitting scans, has the higher highs

0 · Reply

MrAlientrader Sep. 3 at 2:28 PM

$CALC short interest slightly up again, and insiders keep buying. Rarely seen insiders buy so often, something big is coming. Please short more

0 · Reply

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 12, 2025, 7:00 AM EDT - 4 weeks ago

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Jul 8, 2025, 7:00 AM EDT - 2 months ago

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jun 25, 2025, 7:00 AM EDT - 2 months ago

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

Jun 12, 2025, 7:00 AM EDT - 3 months ago

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

May 14, 2025, 7:00 AM EDT - 4 months ago

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Apr 17, 2025, 7:00 AM EDT - 5 months ago

CalciMedica Announces Presentations at Upcoming Medical Meetings

Apr 1, 2025, 7:00 AM EDT - 5 months ago

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

Mar 27, 2025, 7:00 AM EDT - 6 months ago

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

Mar 5, 2025, 7:00 AM EST - 6 months ago

CalciMedica Secures Credit Facility for Up to $32.5 Million

Mar 4, 2025, 7:00 AM EST - 6 months ago

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

Feb 19, 2025, 7:00 AM EST - 7 months ago

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

Feb 3, 2025, 4:05 PM EST - 7 months ago

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 14, 2025, 7:00 AM EST - 8 months ago

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

Nov 21, 2024, 8:00 AM EST - 10 months ago

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 7:00 AM EST - 10 months ago

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

Nov 7, 2024, 7:00 AM EST - 11 months ago

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

Oct 30, 2024, 10:11 PM EDT - 11 months ago

CalciMedica Announces Pricing of Public Offering of Common Stock

Oct 30, 2024, 4:50 PM EDT - 11 months ago

CalciMedica Announces Proposed Public Offering of Common Stock

Oct 30, 2024, 7:00 AM EDT - 11 months ago

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

Oct 28, 2024, 4:05 PM EDT - 11 months ago

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Oct 16, 2024, 8:00 AM EDT - 11 months ago

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

Sep 3, 2024, 8:00 AM EDT - 1 year ago

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 12, 2024, 4:10 PM EDT - 1 year ago

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

Jul 9, 2024, 7:30 AM EDT - 1 year ago

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

Jul 8, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

Jul 1, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Set to Join Russell Microcap® Index

Jun 27, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Jun 26, 2024, 4:05 PM EDT - 1 year ago

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

May 13, 2024, 4:05 PM EDT - 1 year ago

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

May 7, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

Apr 24, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

Mar 28, 2024, 7:00 AM EDT - 1 year ago

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

Mar 13, 2024, 8:00 AM EDT - 1 year ago

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

Feb 28, 2024, 6:57 PM EST - 1 year ago

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

Feb 13, 2024, 8:00 AM EST - 1 year ago

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

Feb 7, 2024, 4:05 PM EST - 1 year ago

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 22, 2024, 8:00 AM EST - 1 year ago

CalciMedica Announces Private Placement of up to Approximately $55 Million

Nov 9, 2023, 7:00 AM EST - 2 years ago

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Nov 2, 2023, 9:15 AM EDT - 2 years ago

CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition

Sep 6, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Announces Upcoming Presentations and Events in September

Aug 31, 2023, 7:30 AM EDT - 2 years ago

CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023

Aug 9, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

Jun 12, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Announces Relisting on Nasdaq

Jun 6, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)

May 23, 2023, 8:00 AM EDT - 2 years ago

Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development

May 23, 2023, 7:30 AM EDT - 2 years ago

CalciMedica Expands Executive Team with New Appointments

May 15, 2023, 8:55 AM EDT - 2 years ago

CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Mar 20, 2023, 4:25 PM EDT - 2 years ago

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

MrAlientrader Sep. 12 at 6:16 PM

$CALC haven’t seen a stock has insiders buy so often

0 · Reply

MrAlientrader Sep. 11 at 8:21 PM

$CALC i was waiting for the drop but my order at $3.25 placed yesterday did not get filled even the price shows today’s low at $3.15

0 · Reply

pablo4 Sep. 11 at 4:12 PM

$CALC https://www.sec.gov/Archives/edgar/data/1534133/000141588925024256/xslF345X05/form4-09112025_120901.xml CBO stepping up and adding again. I've never seen insider buying this regular.

1 · Reply

InfinityVenom Sep. 10 at 5:59 PM

$CALC Im in here.

0 · Reply

MrAlientrader Sep. 10 at 2:15 PM

$CALC i almost accumulated every major dip

0 · Reply

sh64 Sep. 9 at 5:09 PM

$CALC nice

0 · Reply

OffComesTheShirt Sep. 9 at 5:09 PM

$CALC 15% Off Comes The Pants

0 · Reply

OffComesTheShirt Sep. 9 at 4:52 PM

$CALC 14% Off Comes The Shirt

0 · Reply

kshonstocks Sep. 9 at 4:27 PM

$CALC hitting scans, has the higher highs

0 · Reply

MrAlientrader Sep. 3 at 2:28 PM

$CALC short interest slightly up again, and insiders keep buying. Rarely seen insiders buy so often, something big is coming. Please short more

0 · Reply

PLATINUM_TRADES Sep. 3 at 12:17 AM

$CALC up on this one with a 13G insider buy tomorrow looks to be awesome $3.25 to break for more🚨🚨

0 · Reply

DARKP00L Sep. 2 at 7:40 PM

$CALC this stock is attracting a lot of interest. Be prepared for possible changes!

0 · Reply

pablo4 Sep. 2 at 6:24 PM

$CALC I think my feed gives me updates on insider buying very efficiently as it seems I see them as soon as they hit the wire. Guess what?? Another form 4 filing by the chief business officer....this time a purchase of 10,000 total shares (9200 and 800). This stock is going to explode soon, IMO. The CALC mgt team must be very, very excited about the prospects of their kidney trial that will give us results in several months. https://www.sec.gov/Archives/edgar/data/1534133/000141588925023364/xslF345X05/form4-09022025_050918.xml

1 · Reply

OffComesTheShirt Sep. 2 at 3:46 PM

$CALC 20% Off Comes The Underwear! Now it's a party.

0 · Reply

sh64 Sep. 2 at 3:32 PM

$CALC nice

0 · Reply

OffComesTheShirt Sep. 2 at 3:30 PM

$CALC 18% Off Comes The Pants!

0 · Reply

MrAlientrader Sep. 2 at 3:02 PM

$CALC short interest at historical high, oh shorts,

0 · Reply

pablo4 Sep. 2 at 3:00 PM

$CALC volume has come and it's cranking it up

0 · Reply

MrAlientrader Aug. 29 at 1:53 PM

$CALC shorts become more active now on price compressing as they now have larger short position. Probably good time for a short squeeze

0 · Reply

MrAlientrader Aug. 28 at 8:01 PM

$CALC there are lots naked shorts now

0 · Reply

MrAlientrader Aug. 28 at 7:18 PM

$CALC the short fee up significantly indicate lots new short position opened recently

1 · Reply

pablo4 Aug. 25 at 2:06 PM

$CALC The CBO "buys again!" How many more insider buys will it take before this thing explodes? https://www.sec.gov/Archives/edgar/data/1534133/000141588925022850/xslF345X05/form4-08252025_090801.xml

0 · Reply

Market Cap	44.29M
Revenue (ttm)	0.00
Net Income (ttm)	-13.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	68,500
Avg Vol	88,876
Day's Range	N/A - N/A
Shares Out	13.97M
Stochastic %K	45%
Beta	1.32
Analysts	Strong Sell
Price Target	$17.00